Clinicopathologic Features And Prognosis Of Osteosarcoma In Turkish Adults
| العنوان: | Clinicopathologic Features And Prognosis Of Osteosarcoma In Turkish Adults |
|---|---|
| المؤلفون: | Nuriye Ozdemir, Sercan Aksoy, Ayse Seker, Mehmet Metin Seker, Nurullah Zengin, Dogan Uncu |
| المساهمون: | Beslenme ve Diyetetik, [Seker, Mehmet Metin] Cumhuriyet Univ, Fac Med, Dept Med Oncol, Sivas, Turkey -- [Seker, Ayse] Publ Hlth Directorate, Sivas, Turkey -- [Aksoy, Sercan] Hacettepe Univ, Inst Canc, Dept Med Oncol, Ankara, Turkey -- [Ozdemir, Nuriye -- Uncu, Dogan -- Zengin, Nurullah] Ankara Numune Training & Res Hosp, Dept Med Oncol, Ankara, Turkey, Aksoy, Sercan -- 0000-0003-4984-1049 |
| بيانات النشر: | Asian Pacific Organization Cancer Prevention, 2014. |
| سنة النشر: | 2014 |
| مصطلحات موضوعية: | Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Adolescent, Turkey, Epidemiology, medicine.medical_treatment, Bone Neoplasms, Disease-Free Survival, Cohort Studies, Young Adult, Internal medicine, medicine, adults, Humans, Progression-free survival, Young adult, Pathological, Aged, Neoplasm Staging, Retrospective Studies, Chemotherapy, Osteosarcoma, L-Lactate Dehydrogenase, treatment, business.industry, Public Health, Environmental and Occupational Health, Retrospective cohort study, Middle Aged, Alkaline Phosphatase, Prognosis, medicine.disease, Chemotherapy regimen, Surgery, Fractures, Spontaneous, Female, prognosis, business, Cohort study |
| الوصف: | WOS: 000338633500034 PubMed ID: 24870753 Background: Osteosarcomas are the most common solid malignancies of bone. In the last two decades there have been no concrete developments in their systemic treatment. In this trial we aimed to present our osteosarcoma patient clinical and demographic outcomes. Materials and Methods: Patients treated and followed up for osteosarcoma in Ankara Numune Education and Research Hospital from 2002 to 2012 were reviewed retrospectively. Results: A total of 21 patients (15 male, 6 female) were diagnosed with osteosarcoma. The disease was located at extremities in 76% and in 14% was metastatic at the time of diagnosis. Median disease free survival (DFS) was 36 months in non-metastatic patients and median progression free survival (PFS) was 2 months in metastatic patients (p |
| وصف الملف: | text/plain; application/pdf |
| اللغة: | English |
| تدمد: | 0003-3863 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd7f7d2e9061bbc1a8fbe942af030249Test http://hdl.handle.net/11655/20788Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....bd7f7d2e9061bbc1a8fbe942af030249 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 00033863 |
|---|